Psivida Corp:
* Psivida submits marketing authorization application (maa) for approval of durasert™ three-year treatment for posterior segment uveitis in European Union
* Psivida Corp - submitted MAA to EMA, seeking approval to market co's durasert three-year treatment for posterior segment uveitis in European Union Source text for Eikon: Further company coverage: